Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Feb;140(2):427–447.

Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

R Moll 1, A Löwe 1, J Laufer 1, W W Franke 1
PMCID: PMC1886432  PMID: 1371204

Abstract

The authors have recently identified a new cytokeratin (CK) polypeptide, CK 20, whose expression is almost entirely confined to the gastric and intestinal epithelium, urothelium, and Merkel cells. Seven monoclonal antibodies (MAbs) specific for CK 20 were raised and characterized by applying immunoblotting and immunocytochemical screening. All of them reacted on frozen tissue sections. A further MAb, IT-Ks20.8, recognized CK 20 in sections of formalin-fixed, paraffin-embedded tissue samples. A total of 711 cases of primary and metastatic cancer, mostly carcinomas, were analyzed immunohistochemically for CK-20 expression, using CK-20 specific guinea-pig antibodies and MAbs. The expression spectrum of CK 20 in carcinomas resembled that seen in the corresponding normal epithelia of origin. CK-20 positivity was seen in the vast majority of adenocarcinomas of the colon (89/93 cases), mucinous ovarian tumors, transitional-cell and Merkel-cell carcinomas and frequently also in adenocarcinomas of the stomach, bile system, and pancreas. Most squamous cell carcinomas in general and most adenocarcinomas from other sites (breast, lung, endometrium), nonmucinous tumors of the ovary, and small-cell lung carcinomas were essentially or completely negative. The authors propose to use CK 20 as a diagnostic marker valuable in distinguishing different types of carcinomas, notably when presenting as metastases.

Full text

PDF
427

Images in this article

438Figure 6
on p.438
431Figure 1
on p.431
431Figure 2
on p.431
431Figure 3
on p.431
432Figure 4
on p.432
433Figure 5
on p.433
439Figure 7
on p.439
440Figure 8
on p.440
441Figure 9
on p.441
442Figure 10
on p.442

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achtstaetter T., Hatzfeld M., Quinlan R. A., Parmelee D. C., Franke W. W. Separation of cytokeratin polypeptides by gel electrophoretic and chromatographic techniques and their identification by immunoblotting. Methods Enzymol. 1986;134:355–371. doi: 10.1016/0076-6879(86)34102-8. [DOI] [PubMed] [Google Scholar]
  2. Achtstätter T., Fouquet B., Rungger-Brändle E., Franke W. W. Cytokeratin filaments and desmosomes in the epithelioid cells of the perineurial and arachnoidal sheaths of some vertebrate species. Differentiation. 1989 May;40(2):129–149. doi: 10.1111/j.1432-0436.1989.tb00822.x. [DOI] [PubMed] [Google Scholar]
  3. Achtstätter T., Moll R., Moore B., Franke W. W. Cytokeratin polypeptide patterns of different epithelia of the human male urogenital tract: immunofluorescence and gel electrophoretic studies. J Histochem Cytochem. 1985 May;33(5):415–426. doi: 10.1177/33.5.2580881. [DOI] [PubMed] [Google Scholar]
  4. Altman E., Cadman E. An analysis of 1539 patients with cancer of unknown primary site. Cancer. 1986 Jan 1;57(1):120–124. doi: 10.1002/1097-0142(19860101)57:1<120::aid-cncr2820570124>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. Azumi N., Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol. 1987 Sep;88(3):286–296. doi: 10.1093/ajcp/88.3.286. [DOI] [PubMed] [Google Scholar]
  6. Blobel G. A., Moll R., Franke W. W., Kayser K. W., Gould V. E. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol. 1985 Nov;121(2):235–247. [PMC free article] [PubMed] [Google Scholar]
  7. Blobel G. A., Moll R., Franke W. W., Vogt-Moykopf I. Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(4):407–429. doi: 10.1007/BF02889883. [DOI] [PubMed] [Google Scholar]
  8. Broers J. L., Ramaekers F. C., Rot M. K., Oostendorp T., Huysmans A., van Muijen G. N., Wagenaar S. S., Vooijs G. P. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res. 1988 Jun 1;48(11):3221–3229. [PubMed] [Google Scholar]
  9. Bártek J., Bártková J., Taylor-Papadimitriou J., Rejthar A., Kovarík J., Lukás Z., Vojtesek B. Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J. 1986 Oct;18(10):565–575. doi: 10.1007/BF01675198. [DOI] [PubMed] [Google Scholar]
  10. Cooper D., Schermer A., Sun T. T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985 Mar;52(3):243–256. [PubMed] [Google Scholar]
  11. Debus E., Moll R., Franke W. W., Weber K., Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol. 1984 Jan;114(1):121–130. [PMC free article] [PubMed] [Google Scholar]
  12. Denk H., Krepler R., Lackinger E., Artlieb U., Franke W. W. Biochemical and immunocytochemical analysis of the intermediate filament cytoskeleton in human hepatocellular carcinomas and in hepatic neoplastic nodules of mice. Lab Invest. 1982 Jun;46(6):584–596. [PubMed] [Google Scholar]
  13. Dockhorn-Dworniczak B., Franke W. W., Schröder S., Czernobilsky B., Gould V. E., Böcker W. Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas. Differentiation. 1987;35(1):53–71. doi: 10.1111/j.1432-0436.1987.tb00151.x. [DOI] [PubMed] [Google Scholar]
  14. Ellis I. O., Hitchcock A. Tumour marker immunoreactivity in adenocarcinoma. J Clin Pathol. 1988 Oct;41(10):1064–1067. doi: 10.1136/jcp.41.10.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fischer H. P., Altmannsberger M., Weber K., Osborn M. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects. Am J Pathol. 1987 Jun;127(3):530–537. [PMC free article] [PubMed] [Google Scholar]
  16. Franke W. W., Moll R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation. 1987;36(2):145–163. doi: 10.1111/j.1432-0436.1987.tb00189.x. [DOI] [PubMed] [Google Scholar]
  17. Franke W. W., Schiller D. L., Moll R., Winter S., Schmid E., Engelbrecht I., Denk H., Krepler R., Platzer B. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol. 1981 Dec 25;153(4):933–959. doi: 10.1016/0022-2836(81)90460-5. [DOI] [PubMed] [Google Scholar]
  18. Fuchs E., Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell. 1980 Apr;19(4):1033–1042. doi: 10.1016/0092-8674(80)90094-x. [DOI] [PubMed] [Google Scholar]
  19. Fuchs E., Tyner A. L., Giudice G. J., Marchuk D., RayChaudhury A., Rosenberg M. The human keratin genes and their differential expression. Curr Top Dev Biol. 1987;22:5–34. doi: 10.1016/s0070-2153(08)60097-6. [DOI] [PubMed] [Google Scholar]
  20. Gould V. E., Moll R., Moll I., Lee I., Franke W. W. Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias, and neoplasms. Lab Invest. 1985 Apr;52(4):334–353. [PubMed] [Google Scholar]
  21. Gown A. M., Vogel A. M. Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol. 1985 Oct;84(4):413–424. doi: 10.1093/ajcp/84.4.413. [DOI] [PubMed] [Google Scholar]
  22. Gröne H. J., Weber K., Helmchen U., Osborn M. Villin--a marker of brush border differentiation and cellular origin in human renal cell carcinoma. Am J Pathol. 1986 Aug;124(2):294–302. [PMC free article] [PubMed] [Google Scholar]
  23. Hoefler H., Kerl H., Rauch H. J., Denk H. New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma. Am J Dermatopathol. 1984 Dec;6(6):525–530. doi: 10.1097/00000372-198412000-00002. [DOI] [PubMed] [Google Scholar]
  24. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  25. Huszar M., Gigi-Leitner O., Moll R., Franke W. W., Geiger B. Monoclonal antibodies to various acidic (type I) cytokeratins of stratified epithelia. Selective markers for stratification and squamous cell carcinomas. Differentiation. 1986;31(2):141–153. doi: 10.1111/j.1432-0436.1986.tb00395.x. [DOI] [PubMed] [Google Scholar]
  26. Kabawat S. E., Bast R. C., Welch W. R., Knapp R. C., Colvin R. B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol. 1983 Jan;79(1):98–104. doi: 10.1093/ajcp/79.1.98. [DOI] [PubMed] [Google Scholar]
  27. Knapp A. C., Franke W. W. Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell. 1989 Oct 6;59(1):67–79. doi: 10.1016/0092-8674(89)90870-2. [DOI] [PubMed] [Google Scholar]
  28. Kyhse-Andersen J. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods. 1984 Dec;10(3-4):203–209. doi: 10.1016/0165-022x(84)90040-x. [DOI] [PubMed] [Google Scholar]
  29. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  30. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  31. Lehto V. P., Stenman S., Miettinen M., Dahl D., Virtanen I. Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol. 1983 Feb;110(2):113–118. [PMC free article] [PubMed] [Google Scholar]
  32. Moll R., Achtstätter T., Becht E., Balcarova-Ständer J., Ittensohn M., Franke W. W. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol. 1988 Jul;132(1):123–144. [PMC free article] [PubMed] [Google Scholar]
  33. Moll R., Dhouailly D., Sun T. T. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;58(2):129–145. doi: 10.1007/BF02890064. [DOI] [PubMed] [Google Scholar]
  34. Moll R. Epithelial tumor markers: cytokeratins and tissue polypeptide antigen (TPA). Curr Top Pathol. 1987;77:71–101. doi: 10.1007/978-3-642-71356-9_4. [DOI] [PubMed] [Google Scholar]
  35. Moll R., Franke W. W. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms. Differentiation. 1985;30(2):165–175. doi: 10.1111/j.1432-0436.1985.tb00528.x. [DOI] [PubMed] [Google Scholar]
  36. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982 Nov;31(1):11–24. doi: 10.1016/0092-8674(82)90400-7. [DOI] [PubMed] [Google Scholar]
  37. Moll R., Krepler R., Franke W. W. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation. 1983;23(3):256–269. doi: 10.1111/j.1432-0436.1982.tb01291.x. [DOI] [PubMed] [Google Scholar]
  38. Moll R., Levy R., Czernobilsky B., Hohlweg-Majert P., Dallenbach-Hellweg G., Franke W. W. Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Lab Invest. 1983 Nov;49(5):599–610. [PubMed] [Google Scholar]
  39. Moll R., Osborn M., Hartschuh W., Moll I., Mahrle G., Weber K. Variability of expression and arrangement of cytokeratin and neurofilaments in cutaneous neuroendocrine carcinomas (Merkel cell tumors): immunocytochemical and biochemical analysis of twelve cases. Ultrastruct Pathol. 1986;10(6):473–495. doi: 10.3109/01913128609007206. [DOI] [PubMed] [Google Scholar]
  40. Moll R., Pitz S., Levy R., Weikel W., Franke W. W., Czernobilsky B. Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas. Hum Pathol. 1991 Oct;22(10):989–1001. doi: 10.1016/0046-8177(91)90007-c. [DOI] [PubMed] [Google Scholar]
  41. Moll R., Robine S., Dudouet B., Louvard D. Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;54(3):155–169. doi: 10.1007/BF02899208. [DOI] [PubMed] [Google Scholar]
  42. Moll R., Schiller D. L., Franke W. W. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol. 1990 Aug;111(2):567–580. doi: 10.1083/jcb.111.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Morgan P. R., Shirlaw P. J., Johnson N. W., Leigh I. M., Lane E. B. Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol. 1987 Apr;16(4):212–222. doi: 10.1111/j.1600-0714.1987.tb02068.x. [DOI] [PubMed] [Google Scholar]
  44. Nagle R. B. Intermediate filaments. Efficacy in surgical pathologic diagnosis. Am J Clin Pathol. 1989 Apr;91(4 Suppl 1):S14–S18. [PubMed] [Google Scholar]
  45. Nagle R. B. Intermediate filaments: a review of the basic biology. Am J Surg Pathol. 1988;12 (Suppl 1):4–16. [PubMed] [Google Scholar]
  46. Nicolson G. L. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 1987 Mar 15;47(6):1473–1487. [PubMed] [Google Scholar]
  47. Osborn M., Mazzoleni G., Santini D., Marrano D., Martinelli G., Weber K. Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch A Pathol Anat Histopathol. 1988;413(4):303–312. doi: 10.1007/BF00783022. [DOI] [PubMed] [Google Scholar]
  48. Osborn M., Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983 Apr;48(4):372–394. [PubMed] [Google Scholar]
  49. Osborn M., van Lessen G., Weber K., Klöppel G., Altmannsberger M. Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest. 1986 Oct;55(4):497–504. [PubMed] [Google Scholar]
  51. Pitz S., Moll R., Störkel S., Thoenes W. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab Invest. 1987 Jun;56(6):642–653. [PubMed] [Google Scholar]
  52. Pruss R. M., Mirsky R., Raff M. C., Thorpe R., Dowding A. J., Anderton B. H. All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell. 1981 Dec;27(3 Pt 2):419–428. doi: 10.1016/0092-8674(81)90383-4. [DOI] [PubMed] [Google Scholar]
  53. Quinlan R. A., Schiller D. L., Hatzfeld M., Achtstätter T., Moll R., Jorcano J. L., Magin T. M., Franke W. W. Patterns of expression and organization of cytokeratin intermediate filaments. Ann N Y Acad Sci. 1985;455:282–306. doi: 10.1111/j.1749-6632.1985.tb50418.x. [DOI] [PubMed] [Google Scholar]
  54. Ramaekers F., Huysmans A., Moesker O., Kant A., Jap P., Herman C., Vooijs P. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest. 1983 Sep;49(3):353–361. [PubMed] [Google Scholar]
  55. Ramaekers F., van Niekerk C., Poels L., Schaafsma E., Huijsmans A., Robben H., Schaart G., Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol. 1990 Mar;136(3):641–655. [PMC free article] [PubMed] [Google Scholar]
  56. Reedy E. A., Heatfield B. M., Trump B. F., Resau J. H. Correlation of cytokeratin patterns with histopathology during neoplastic progression in the rat urinary bladder. Pathobiology. 1990;58(1):15–27. doi: 10.1159/000163561. [DOI] [PubMed] [Google Scholar]
  57. Schaafsma H. E., Ramaekers F. C., van Muijen G. N., Lane E. B., Leigh I. M., Robben H., Huijsmans A., Ooms E. C., Ruiter D. J. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol. 1990 Feb;136(2):329–343. [PMC free article] [PubMed] [Google Scholar]
  58. Shah K. D., Tabibzadeh S. S., Gerber M. A. Comparison of cytokeratin expression in primary and metastatic carcinomas. Diagnostic application in surgical pathology. Am J Clin Pathol. 1987 Jun;87(6):708–715. doi: 10.1093/ajcp/87.6.708. [DOI] [PubMed] [Google Scholar]
  59. Tseng S. C., Jarvinen M. J., Nelson W. G., Huang J. W., Woodcock-Mitchell J., Sun T. T. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell. 1982 Sep;30(2):361–372. doi: 10.1016/0092-8674(82)90234-3. [DOI] [PubMed] [Google Scholar]
  60. Van Eyken P., Sciot R., Paterson A., Callea F., Kew M. C., Desmet V. J. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol. 1988 May;19(5):562–568. doi: 10.1016/s0046-8177(88)80205-3. [DOI] [PubMed] [Google Scholar]
  61. Vojtesek B., Stasková Z., Nenutil R., Bártková J., Kovarík J., Rejthar A., Bártek J. A panel of monoclonal antibodies to keratin no. 7: characterization and value in tumor diagnosis. Neoplasma. 1990;37(3):333–342. [PubMed] [Google Scholar]
  62. Wiedenmann B., Franke W. W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell. 1985 Jul;41(3):1017–1028. doi: 10.1016/s0092-8674(85)80082-9. [DOI] [PubMed] [Google Scholar]
  63. Wu Y. J., Parker L. M., Binder N. E., Beckett M. A., Sinard J. H., Griffiths C. T., Rheinwald J. G. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell. 1982 Dec;31(3 Pt 2):693–703. doi: 10.1016/0092-8674(82)90324-5. [DOI] [PubMed] [Google Scholar]
  64. Yeger H., Baumal R., Kahn H. J., Duwe G., Phillips M. J. The use of cytoskeletal characteristics of tumor cells for the diagnosis of colon and breast adenocarcinomas. Am J Clin Pathol. 1986 Dec;86(6):697–705. doi: 10.1093/ajcp/86.6.697. [DOI] [PubMed] [Google Scholar]
  65. van Muijen G. N., Ruiter D. J., Franke W. W., Achtstätter T., Haasnoot W. H., Ponec M., Warnaar S. O. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp Cell Res. 1986 Jan;162(1):97–113. doi: 10.1016/0014-4827(86)90429-5. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES